Invention Grant
- Patent Title: TFPI inhibitors and methods of use
- Patent Title (中): TFPI抑制剂和使用方法
-
Application No.: US13846359Application Date: 2013-03-18
-
Publication No.: US09018167B2Publication Date: 2015-04-28
- Inventor: Michael Dockal , Rudolf Hartmann , Markus Fries , Friedrich Scheiflinger , Hartmut Ehrlich , Ulrich Reineke , Frank Osterkamp , Thomas Polakowski
- Applicant: Baxter International Inc. , Baxter Healthcare SA
- Applicant Address: US IL Deerfield CH Glattpark (Opfikon)
- Assignee: Baxter International Inc.,Baxter Healthcare SA
- Current Assignee: Baxter International Inc.,Baxter Healthcare SA
- Current Assignee Address: US IL Deerfield CH Glattpark (Opfikon)
- Agency: Marshall, Gerstein & Borun LLP
- Main IPC: A61K38/57
- IPC: A61K38/57 ; C07K14/745 ; C07K14/00 ; C07K14/81 ; G01N33/68 ; C07K7/08 ; A61K38/00
Abstract:
The invention provides peptides that bind Tissue Factor Pathway Inhibitor (TFPI), including TFPI-inhibitory peptides, and compositions thereof. The peptides may be used to inhibit a TFPI, enhance thrombin formation in a clotting factor-deficient subject, increase blood clot formation in a subject, treat a blood coagulation disorder in a subject, purify TFPI, and identify a TFPI-binding compound.
Public/Granted literature
- US20130259863A1 TFPI INHIBITORS AND METHODS OF USE Public/Granted day:2013-10-03
Information query
IPC分类:
